Skip to content
AnalystLens

Leidos Holdings 8-K Report, Financial Results (Oct 29, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 29, 2024
Period End
October 29, 2024
Security
LDOS
In the record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’20Mar ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Material agreement8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed October 29, 2024. Cited figures are marked; the original filing is the authoritative source.

Leidos Holdings, Inc. reported financial results for its third fiscal quarter ended September 27, 2024, in a press release furnished as Exhibit 99.1 to this Form 8-K.

Revenues were $4.19 billiona, up 7% year-over-year, and net income was $362 million, or $2.68 per diluted share, compared with a net loss of $396 million in the prior-year quarter, which included a $699 million pre-tax, non-cash impairment and restructuring charge primarily tied to the Security Enterprise Solutions (SES) reporting unit. Adjusted EBITDA was $596 million with a record 14.2% margin, up from 11.5%, and non-GAAP diluted EPS was $2.93, up 44% year-over-year. Cash flow from operations was $656 million and free cash flow (non-GAAP) was $633 million.

Net bookings were $8.1 billionb for the quarter, a book-to-bill ratio of 1.9, and backlog ended the quarter at $40.6 billion, of which $9.1 billion was funded. Notable awards included a five-year, $331 million Army Global Unified Network contract and a five-year, $303 million Air Force ABMS-DI network contract. The company raised its fiscal 2024 guidance: revenues are now expected at $16.35 to $16.45 billion (previously $16.10 to $16.40 billion), non-GAAP diluted EPS at $9.80 to $10.00 (previously $8.60 to $9.00), and adjusted EBITDA margin at high-12% (previously approximately 12%).

The company also declared a quarterly dividend of $0.40c per share, a 5.3% increase over the prior quarter's dividend, payable December 31, 2024. As of September 27, 2024, Leidos had $1,185 million in cash and cash equivalents and $4.7 billion of debt, and it repurchased $203 million of stock during the quarter.

Key Highlights

  1. Revenues of $4.19 billion, up 7% year-over-year, driven by increased demand across customer segments, especially managed health services.
  2. Net income of $362 million, or $2.68 per diluted share, versus a net loss of $396 million in the year-ago quarter, which included a $699 million pre-tax impairment and restructuring charge.
  3. Adjusted EBITDA of $596 million with a record 14.2% margin, up from 11.5% a year earlier; non-GAAP diluted EPS of $2.93, up 44% year-over-year.
  4. Net bookings of $8.1 billion, a book-to-bill ratio of 1.9 for the quarter, and backlog of $40.6 billion.
  5. Fiscal 2024 guidance raised: revenues of $16.35 to $16.45 billion, non-GAAP diluted EPS of $9.80 to $10.00, and adjusted EBITDA margin in the high-12% range.
  6. Cash flow from operations of $656 million and free cash flow (non-GAAP) of $633 million for the quarter.
  7. Quarterly dividend declared at $0.40 per share, a 5.3% increase over the prior quarter's dividend, with $203 million of share repurchases in the quarter.

Frequently Asked Questions

  1. What drove the improvement in Leidos's profitability this quarter?

    The company attributed higher profitability to increased volumes on managed health services programs and improved program execution and cost control across the company. Health & Civil operating income margin rose to 23.4% from 15.6% a year earlier.

  2. Why are year-over-year net income comparisons not meaningful?

    The prior-year third quarter included a $699 million pre-tax, non-cash impairment and restructuring charge primarily associated with the Security Enterprise Solutions (SES) reporting unit, which produced a net loss of $396 million.

  3. How did Leidos change its fiscal 2024 outlook?

    Leidos raised its revenue guidance to $16.35 to $16.45 billion from $16.10 to $16.40 billion, raised non-GAAP diluted EPS guidance to $9.80 to $10.00 from $8.60 to $9.00, and moved its adjusted EBITDA margin expectation to high-12% from approximately 12%. Operating cash flow guidance was raised to approximately $1.35 billion from approximately $1.30 billion.

  4. What is the company's backlog and how strong were bookings?

    Net bookings totaled $8.1 billion in the quarter, a book-to-bill ratio of 1.9, and backlog at quarter end was $40.6 billion, of which $9.1 billion was funded. The trailing twelve-month book-to-bill ratio was 1.1.

  5. What is the company's balance sheet and capital return position?

    As of September 27, 2024, Leidos had $1,185 million in cash and cash equivalents and $4.7 billion of debt. In the quarter it returned $254 million to shareholders, including $203 million in share repurchases and $51 million in dividends, and declared a $0.40 per share dividend payable December 31, 2024.